SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-19-002206
Filing Date
2019-07-16
Accepted
2019-07-16 13:23:27
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-1 cns_s1a1.htm S-1/A 1099206
2 FORM OF UNDERWRITING AGREEMENT cns_ex0101.htm EX-1.1 251003
3 FORM OF UNDERWRITERS WARRANT AGREEMENT cns_ex0404.htm EX-4.4 89292
4 OPINION cns_ex0501.htm EX-5.1 18586
5 EMPLOYMENT LETTER cns_ex1008.htm EX-10.8 21811
6 EMPLOYMENT LETTER cns_ex1009.htm EX-10.9 21962
7 cns_ex2301.htm EX-23.1 2418
8 GRAPHIC loev_logo.jpg GRAPHIC 571435
9 GRAPHIC malonelogo.jpg GRAPHIC 27582
  Complete submission text file 0001683168-19-002206.txt   2330152
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-232443 | Film No.: 19956771
SIC: 2834 Pharmaceutical Preparations